$250.84+19.01% · 3M
Moving avg
1W+1.95%
1M+2.76%
3M+19.23%
6M+8.35%
YTD+9.39%
1Y+22.55%
3Y+64.73%
5Y+111.84%
52-week range
$187.6285% of range$261.64
Company health
Value0/6
Growth4/6
Profitability4/6
Health3/6
Dividend3/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (6801%)
- Revenue compounding 11% a year
- Pays a 2.6% dividend
Risks
- Richly valued at 127.1x earnings
Key statistics
Valuation
Market cap
$443.18B
Enterprise value
$521.58B
P/E ratio (TTM)
127.13x
P/S ratio (TTM)
7.29x
EV/EBITDA
30.82x
Per share & returns
EPS (TTM)
$2.05
Dividend yield
2.63%
Beta (1Y)
0.28
30-day change
+2.76%
Trading
Volume (24h)
1.65M
Previous close
$248.76
Shares outstanding
1.77B
About AbbVie Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Symbol
ABBV
AbbVie Inc. is a mega-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NYSE (United States) and trade under the ticker ABBV.
Frequently asked questions
What is AbbVie Inc.'s market cap?
AbbVie Inc. (ABBV) has a market capitalization of $443.18B.
What is AbbVie Inc.'s P/E ratio?
AbbVie Inc. trades at a price-to-earnings (P/E) ratio of 127.13.
What exchange does ABBV trade on?
ABBV trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,223.91+0.30%
$1.15T cap
Johnson & JohnsonJNJ
$261.14+0.11%
$629.31B cap
UnitedHealth Group IncorporatedUNH
$402.80-0.69%
$365.80B cap
Roche Holding AGSWX: ROP
CHF 362.00-0.96%
$355.01B cap
Merck & Co., Inc.MRK
$134.68+1.32%
$332.64B cap
Novartis AGSWX: NOVN
CHF 123.94-0.21%
$290.23B cap
AstraZeneca PLCLON: AZN
£117.06+0.03%
$245.23B cap
Amgen Inc.AMGN
$417.29+0.27%
$225.21B cap